Adverse effects on EEG and clinical condition after immunizing children with convulsive disorders

S Nouno1, K Togawa, Y Yamatogi

  • 1Department of Pediatrics, Tamano City Hospital, Japan.

Acta Paediatrica Japonica : Overseas Edition
|August 1, 1990
PubMed

Insights

Immunizations may affect EEG readings in children with epilepsy. While some vaccines showed no adverse effects, others like DPT, DT, and BCG were linked to increased epileptic spikes, necessitating follow-up EEG monitoring.

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Febrile seizures and epilepsy are common in childhood.
  • Immunizations are a critical part of pediatric healthcare.
  • Assessing vaccine safety in children with pre-existing neurological conditions is important.

Purpose of the Study:

  • To evaluate the impact of various immunizations on electroencephalogram (EEG) findings in children with a history of febrile convulsion or epilepsy.
  • To determine if specific vaccines trigger adverse neurological events or alter EEG patterns in this vulnerable population.

Main Methods:

  • A cohort of 61 children with febrile convulsion or epilepsy, seizure-free for at least one year, received 116 immunizations.
  • EEG examinations were conducted before and after immunization in 92 instances.
  • Vaccines administered included Japanese encephalitis, measles, mumps, rubella, diphtheria, acellular pertussis and tetanus (DPT), diphtheria and tetanus (DT), and Bacillus Calmette-Guerin (BCG).

Main Results:

  • No adverse EEG effects were noted following immunizations with Japanese encephalitis, measles, mumps, or rubella vaccines.
  • In contrast, 10 out of 73 immunizations with DPT, DT, or BCG vaccines showed reappearance or increase in epileptic spikes.
  • One child experienced a convulsion seven days post-BCG immunization.

Conclusions:

  • Certain childhood immunizations, particularly DPT, DT, and BCG, may be associated with transient EEG changes in children with epilepsy.
  • While generally safe, these vaccines warrant careful consideration and monitoring in children with convulsive disorders.
  • Follow-up EEG examinations are recommended after immunizing children with a history of seizures or epilepsy.

Related Concept Videos

Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...